GBA1 and Parkinson disease: Although postmortem studies have suggested the possibility of increased intracellular α-synuclein in brains from PD patients carrying GBA mutations, postmortem tissue likely reflects a much more advanced stage of disease pathology (Choi et al., 2012, Gegg et al., 2012).